Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty
- 15 March 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 23 (4) , 907-910
- https://doi.org/10.1016/0735-1097(94)90636-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Is aggressive heparinization necessary for elective ptca?Catheterization and Cardiovascular Diagnosis, 1993
- Activated clotting times and activated partial thromboplastin times in patients undergoing coronary angioplasty who receive bolus doses of heparinCatheterization and Cardiovascular Diagnosis, 1992
- The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1992
- Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.Heart, 1990
- Adequate heparinization during PTCA: Assessment using activated clotting timesCatheterization and Cardiovascular Diagnosis, 1989
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975
- Activated Coagulation Time of Whole BloodJAMA, 1966